Clinical Trial Update: Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase I clinical trial update for GNC-038 in non-Hodgkin lymphoma and acute lymphoblastic leukemia; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• GNC-038

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING